80.44MMarket Cap-1949P/E (TTM)
3.130High3.050Low12.83KVolume3.050Open3.090Pre Close39.51KTurnover0.11%Turnover RatioLossP/E (Static)26.29MShares6.47052wk High1.57P/B36.94MFloat Cap1.13152wk Low--Dividend TTM12.07MShs Float17.200Historical High--Div YieldTTM2.59%Amplitude1.131Historical Low3.080Avg Price1Lot Size
LAVA Therapeutics Stock Forum
LAVA Therapeutics N.V., a leader in the biotechnology sector, has recently announced a significant clinical development milestone achieved by Pfizer for the drug PF-08046052. This milestone has prompted the first payment of $7 million to LAVA, marking a notable event in the field of immuno-oncology. $LAVA Therapeutics(LVTX.US)$
https://stockregion.app/p/biotech-leader-announces-7m-milestone
No comment yet